Sirio Pharma (300791) — Strategic Asset Allocation Index
Sirio Pharma (300791) has a Strategic Asset Allocation Index of 64.4% as of June 2023. Strategic assets (PP&E of CN¥1.87 Billion plus long-term investments of CN¥-) total CN¥1.87 Billion, measured against net assets of CN¥2.91 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Sirio Pharma Strategic Asset Allocation Index (2016–2022)
This chart shows how Sirio Pharma's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 64.4%, representing strategic assets of CN¥1.87 Billion against net assets of CN¥2.91 Billion CNY. Explore how efficiently does Sirio Pharma generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Sirio Pharma (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Sirio Pharma from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Sirio Pharma (300791) market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 49.3% | CN¥1.33 Billion | CN¥1.33 Billion | CN¥- | CN¥2.70 Billion | ▲ +3.2 pp |
| 2021 | 46.1% | CN¥1.17 Billion | CN¥1.17 Billion | CN¥- | CN¥2.54 Billion | ▲ +10.9 pp |
| 2020 | 35.2% | CN¥768.05 Million | CN¥768.05 Million | CN¥- | CN¥2.18 Billion | ▲ +2.8 pp |
| 2019 | 32.4% | CN¥629.25 Million | CN¥629.25 Million | CN¥- | CN¥1.95 Billion | ▼ -41.6 pp |
| 2018 | 74.0% | CN¥580.02 Million | CN¥580.02 Million | CN¥- | CN¥784.05 Million | ▲ +6.8 pp |
| 2017 | 67.2% | CN¥389.76 Million | CN¥389.76 Million | CN¥- | CN¥580.20 Million | ▲ +4.4 pp |
| 2016 | 62.8% | CN¥292.13 Million | CN¥292.13 Million | CN¥- | CN¥464.98 Million | — |